Detalhe da pesquisa
1.
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 390(14): 1265-1276, 2024 Apr 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38598794
2.
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(18): 1672-1684, 2023 Nov 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37870974
3.
Prognostic significance of circulating tumor cells and tumor related transcripts in small cell lung cancer: A step further to clinical implementation.
Int J Cancer
; 154(12): 2189-2199, 2024 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38353516
4.
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
Br J Cancer
; 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38750115
5.
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Int J Mol Sci
; 25(7)2024 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38612799
6.
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(10): 944-957, 2020 09 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32877583
7.
Effect of short-term storage of blood samples on gene expression in lung cancer patients.
Clin Chem Lab Med
; 61(2): 294-301, 2023 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36395488
8.
Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer.
Invest New Drugs
; 40(2): 215-223, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34596822
9.
Rovalpituzumab tesirine resistance: analysis of a corresponding small cell lung cancer and circulating tumor cell line pair.
Anticancer Drugs
; 33(3): 300-307, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34924498
10.
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Lancet Oncol
; 22(1): 51-65, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33285097
11.
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
N Engl J Med
; 379(23): 2220-2229, 2018 12 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30280641
12.
Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 379(21): 2027-2039, 2018 11 22.
Artigo
Inglês
| MEDLINE | ID: mdl-30280657
13.
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
N Engl J Med
; 378(22): 2078-2092, 2018 May 31.
Artigo
Inglês
| MEDLINE | ID: mdl-29658856
14.
Alectinib following brigatinib: an efficient sequence for the treatment of advanced anaplastic lymphoma kinase-positive lung cancer patients.
Anticancer Drugs
; 32(1): 105-110, 2021 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32868645
15.
Pre-radiosurgery leucocyte ratios and modified glasgow prognostic score predict survival in non-small cell lung cancer brain metastases patients.
J Neurooncol
; 151(2): 257-265, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33179214
16.
Plain language summary of the final results from the GioTag study.
Future Oncol
; 17(25): 3285-3290, 2021 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34107727
17.
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 21(3): 387-397, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32035514
18.
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Lancet
; 394(10212): 1929-1939, 2019 11 23.
Artigo
Inglês
| MEDLINE | ID: mdl-31590988
19.
Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter Study.
Oncologist
; 25(12): e1930-e1955, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33010094
20.
Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines.
Invest New Drugs
; 38(4): 946-955, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31446534